Ecolex Logo
The gateway to
environmental law
Search results » Legislation

Order No. 17-N of the Ministry of Public Health validating Sanitary and hygienic requirements for disinfectants, insecticides and hazardous substances No. 2.1.7.006-14.

Country/Territory
Armenia
Document type
Regulation
Date
2014
Source
FAO, FAOLEX
Subject
Agricultural & rural development, Environment gen., Cultivated plants
Keyword
Disinfection/disinfestation Biological control agents Public health Hazardous substances Monitoring Toxicity/poisoning Packaging/labelling
Geographical area
Asia, CIS (Commonwealth of Independent States), Europe, Europe and Central Asia, Landlocked Developing Nations, Western Asia
Entry into force notes
This Order enters into force on 11 July 2014.
Abstract

These requirements apply to insecticides, antioxidants, disinfectants and other similar substances packed in containers or in packages for retail trade, or ready-made preparations or products that are designed for everyday life-time medical care for use in organizations providing assistance and service, and other facilities, ensuring the safety of human life and health. The criteria for the safety assessment of substances affecting disinfectants shall be as follows: (a) acute, subacute, chronic toxicity, including the effects on human health and individual effects assessment (allergen, reproductive toxicity, teratogenicity, mutagenicity, carcinogenicity, embryo); (b) technical products of the registered disinfectant (substance, the affected substances); (c) compliance with the technical product of the manufacturer; (d) hazardous (toxicological) mixtures of technical products; (e) availability of metabolites; (f) hygienic standards of the affected substances in the working zones, atmospheric air in the residential areas, the content of substances in water and soil of the reservoirs and the environment; with the use of monitoring data (if available). Preparation of microorganisms (bacteria) production stages and ready-made forms of biofuels, evaluation criteria shall be as follows: (a) conditions of origin and cultivation, the method of identifying it, strain distribution; (b) pathogens of bacteria (virality, toxicity); (c) the irritant effect on the eye mucous membrane; (d) microorganisms' sensitivity and immunotherapeutic effect on the skin or upper respiratory tract infections; and (e) criteria for the limitation of harmfulness during chronic trials.

Full text
Armenian
Website
www.arlis.am